Presentation TCT 2017 Topic 2: Protect the Brain Cerebral Protection During TAVR Should Be Routine CON! Presenter: Adrian P. Banning, Ted Feldman, Daniel J. Blackman November 01, 2017
Presentation TCT 2017 When to Use Cerebral Protection During TAVR Presenter: Alfredo Trento, Alexandra J. Lansky November 01, 2017
Presentation TCT 2017 Topic 2: Protect the Brain Cerebral Protection During TAVR Should Be Routine - PRO! Presenter: Adrian P. Banning, Ted Feldman, Eberhard Grube November 01, 2017
Presentation TCT 2017 A Propensity Score Analysis of Matched TAVR Patients With and Without Cerebral Protection Presenter: Jochen Wöhrle October 31, 2017
Presentation TCT 2017 TCT 36: Cerebral Embolic Protection During Transfemoral Aortic Valve Replacement Reduces Death and Stroke Compared to Unprotected Procedure in All Subgroups Presenter: Reginald I. Low, Michael J. Rinaldi, Julia Seeger October 31, 2017
Presentation TCT 2017 Taped and Edited Live-Case of the Use of a TriGuard Cerebral Protection Device During TAVR With Sapien 3 Presenter: Francesco Saia, Gerhard C. Schuler, Pieter R. Stella October 31, 2017
Presentation TCT 2017 Germany Presents: Case Introduction - TAVR in a Low-Risk Patient With Cerebral Embolic Protection Presenter: Dariusz Dudek, Martin Hudec, Julia Seeger October 30, 2017
Manuscript Cerebral Embolic Protection: Not Enough Evidence to Support Routine Clinical Use August 14, 2017
News Industry News Keystone Heart Ltd to Accelerate Trials for Advanced Device to Protect Brain During Heart Procedures August 01, 2017
News Industry News Innovative Cardiovascular Solutions Raises $5.0 Million in Series B Financing for Advanced Device Development and Initiation of U.S. Clinical Activities July 11, 2017
News Conference News TVT 2017 Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows Michael O'Riordan June 15, 2017
News Conference News TVT 2017 Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10 Shelley Wood June 12, 2017
News Conference News EuroPCR 2017 Embolic Protection During TAVR Reduces Volume of Cerebral Lesions, but Clinical Benefit Not Evident: Meta-analysis Michael O'Riordan May 26, 2017
News Conference News EuroPCR 2017 More Early Stroke With SAVR Than TAVR in SURTAVI Shelley Wood May 18, 2017
Presentation ACC 2017 Cerebral Embolic Protection In Patients Undergoing Surgical Aortic Valve Replacement (SAVR) Presenter: Michael Mack March 20, 2017
News Conference News ACC 2017 Cerebral Embolic Protection During Surgical AVR Fails to Show a Benefit Todd Neale March 19, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017